Amgen Earnings Preview for Q2 2026

Biotechnology company Amgen (AMGN) is set to report second-quarter earnings after the market closes on August 5, 2026. Analysts expect a slight decline in diluted EPS compared to last year but note consistent outperformance against Wall Street estimates over recent quarters.

By Kritika Sarmah Mon, July 20, 2026 at 3:35 PM GMT+3 2 min read · Yahoo Finance · July 20, 2026, 12:35 UTC

Amgen Earnings Preview for Q2 2026

Tickers: $AMGN $XLV

Topics: Biotechnology Investing Pharmaceuticals

Read the full article at Yahoo Finance

More World news

Mercury Insurance Issues Safety Guidelines for Portable Generator Use During Power Outages PR Newswire · November 12, 2026, 14:06 UTC
Paratus Appoints New Senior Leadership to Drive Expansion into Asset-Backed Optimisation PR Newswire · November 12, 2026, 14:03 UTC
Transamerica Partners with Congruent Solutions to Modernize Retirement Plan Payroll Administration PR Newswire · November 12, 2026, 14:00 UTC
Kindo Raises $57.6 Million Total to Scale Enterprise AI Agent Management Platform PR Newswire · November 12, 2026, 14:00 UTC
Texans Credit Union Introduces Cash Back Checking and Ignite Youth Banking Suite PR Newswire · November 12, 2026, 14:03 UTC
Apple Announces Preorders for Select Smart Home Collection Accessories The Verge · November 12, 2026, 14:00 UTC
SolaREIT Surpasses $8.5 Billion Milestone in Clean Energy Land Financing PR Newswire · November 12, 2026, 14:00 UTC
Avalara Launches Native 1099 E-Filing Integration for Workday Financial Management PR Newswire · November 12, 2026, 14:00 UTC
Rocket Companies Appoints Datadog COO Adam Blitzer to Board of Directors PR Newswire · November 12, 2026, 14:00 UTC
ALKEME Insurance Announces 'ALKEME Bowl' Sponsorship of Arizona vs. Utah College Football Matchup PR Newswire · November 12, 2026, 14:00 UTC